Skip to main content

MoneyWorks4Me

Syngene International informs about update

23 Dec 2023 Evaluate

Syngene International has informed about update on the acquisition of biologics manufacturing facility from Stelis Biopharma. 

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sagility 43.96
Prime Focus 286.05
Indegene 622.95
Syngene Internatl. 434.80
Knowledge RealtyTrt. 111.20
View more..